These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23458066)

  • 21. Blood pressure and cardiovascular morbidity risk in type 2 diabetes with hypertension over a decade of follow-up: evidence for J-shaped phenomenon.
    Riyahi-Alam S; Derakhshan A; Mansournia MA; Mansournia N; Almasi M; Azizi F; Hadaegh F
    J Hum Hypertens; 2017 Jun; 31(6):415-421. PubMed ID: 28124685
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enduring direct association of baseline plasma renin activity with all-cause and cardiovascular mortality in hypertensive patients.
    Gonzalez MC; Cohen HW; Sealey JE; Laragh JH; Alderman MH
    Am J Hypertens; 2011 Nov; 24(11):1181-6. PubMed ID: 21938071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Different obesity phenotypes, and incident cardiovascular disease and mortality events in elderly Iranians: Tehran lipid and glucose study.
    Mirbolouk M; Asgari S; Sheikholeslami F; Mirbolouk F; Azizi F; Hadaegh F
    Geriatr Gerontol Int; 2015 Apr; 15(4):449-56. PubMed ID: 24750352
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
    Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive accuracy of the 'Framingham's general CVD algorithm' in a Middle Eastern population: Tehran Lipid and Glucose Study.
    Bozorgmanesh M; Hadaegh F; Azizi F
    Int J Clin Pract; 2011 Mar; 65(3):264-73. PubMed ID: 21314863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integration of Diabetes Mellitus and Hypertension on Major Cardiovascular Events: An Experience From a 15-year Follow-up Cohort Study in EMR.
    Sadeghi M; Teimouri-Jervekani Z; Roohafza H; Talaei M; Paknahad MH; Dianatkhah M; Boshtam M; Sarrafzadegan N
    Curr Diabetes Rev; 2024 Aug; ():. PubMed ID: 39129153
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
    Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of awareness, treatment and control of hypertension on cardiovascular and all-cause mortality in a community-based population.
    Barengo NC; Kastarinen M; Antikainen R; Nissinen A; Tuomilehto J
    J Hum Hypertens; 2009 Dec; 23(12):808-16. PubMed ID: 19369956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intermittent claudication in the Erfurt Male Cohort (ERFORT) Study: its determinants and the impact on mortality. A population-based prospective cohort study with 30 years of follow-up.
    Kollerits B; Heinrich J; Pichler M; Rantner B; Klein-Weigel P; Wölke G; Brasche S; Strube G; Kronenberg F;
    Atherosclerosis; 2008 May; 198(1):214-22. PubMed ID: 17950299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The combined impact of blood pressure category and glucose abnormality on the incidence of cardiovascular diseases in a Japanese urban cohort: the Suita Study.
    Kokubo Y; Okamura T; Watanabe M; Higashiyama A; Ono Y; Miyamoto Y; Furukawa Y; Kamide K; Kawanishi K; Okayama A; Yoshimasa Y
    Hypertens Res; 2010 Dec; 33(12):1238-43. PubMed ID: 20927111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension, concurrent cardiovascular risk factors and mortality: the Singapore Cardiovascular Cohort Study.
    Lee J; Ma S; Heng D; Chew S; Hughes K; Tai E
    J Hum Hypertens; 2008 Jul; 22(7):468-74. PubMed ID: 18337755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index.
    Newman AB; Sutton-Tyrrell K; Vogt MT; Kuller LH
    JAMA; 1993 Jul; 270(4):487-9. PubMed ID: 8147959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of macrovascular disease in patients with type 2 diabetes mellitus.
    Abu-Lebdeh HS; Hodge DO; Nguyen TT
    Mayo Clin Proc; 2001 Jul; 76(7):707-12. PubMed ID: 11444403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systolic and diastolic blood pressure, mean arterial pressure and pulse pressure for prediction of cardiovascular events and mortality in a Middle Eastern population.
    Hadaegh F; Shafiee G; Hatami M; Azizi F
    Blood Press; 2012 Feb; 21(1):12-8. PubMed ID: 21679012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Silent coronary artery disease and incidence of cardiovascular and mortality events at different levels of glucose regulation; results of greater than a decade follow-up.
    Hadaegh F; Ehteshami-Afshar S; Hajebrahimi MA; Hajsheikholeslami F; Azizi F
    Int J Cardiol; 2015 Mar; 182():334-9. PubMed ID: 25585379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of glycaemic control on cardiovascular disease in diabetic American Indians: the Strong Heart Study.
    Lu WQ; Resnick HE; Jablonski KA; Jain AK; Jones KL; Robbins DC; Howard BV
    Diabet Med; 2004 Apr; 21(4):311-7. PubMed ID: 15049931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exercise and cardiovascular outcomes by hypertensive status: NHANES I epidemiological follow-up study, 1971-1992.
    Fang J; Wylie-Rosett J; Alderman MH
    Am J Hypertens; 2005 Jun; 18(6):751-8. PubMed ID: 15925731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Joint effects of history of hypertension at baseline and type 2 diabetes at baseline and during follow-up on the risk of coronary heart disease.
    Hu G; Jousilahti P; Tuomilehto J
    Eur Heart J; 2007 Dec; 28(24):3059-66. PubMed ID: 17981826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience.
    Eberly LE; Cohen JD; Prineas R; Yang L;
    Diabetes Care; 2003 Mar; 26(3):848-54. PubMed ID: 12610048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.